首页> 外文会议>International Symposium on Mechanobiology of Cartilage and Chondrocyte >Dynamic compression counteracts IL-1beta induced i NOS and COX-2 activity by human chondrocytes cultured in agarose constructs
【24h】

Dynamic compression counteracts IL-1beta induced i NOS and COX-2 activity by human chondrocytes cultured in agarose constructs

机译:动态压缩抵消IL-1beta诱导的琼脂糖构建体中的人软骨细胞诱导I NOS和COX-2活性

获取原文

摘要

NO and PGE2 are inflammatory mediators derived from the inducible i NOS and COX enzymes and are potentially important pharmacological targets in OA. Both mechanical loading and IL-1beta will influence the release of NO and PGE2. Accordingly, the current study examines the effect of dynamic compression on NO and PGE2 release by human chondrocytes cultured in agarose constructs in the presence and absence of selective i NOS and COX-2 inhibitors. The current data demonstrate that IL-1beta induced nitrite and PGE2 release and inhibited [H]-thymidine and SO4 incorporation. Inhibitor experiments indicate that 1400W and NS-398 either partially reversed or abolished IL-1beta induced nitrite and PGE2 release. IL-1beta induced inhibition of cell proliferation and proteoglycan synthesis was partially reversed with 1400W but was not influenced by NS-398. For the dynamic loading experiments, 1400W and NS-398 either reduced or abolished the compression-induced inhibition of 'NO and PGE2 release in the presence of IL-1beta. The IL-1beta induced inhibition of cell proliferation was not influenced by 1400W or NS-398 whereas strain-induced stimulation of proteoglycan synthesis in the presence of IL-1beta was enhanced by 1400W. The data obtained using human chondrocytes demonstrate that IL-1beta induced NO and PGE2 release via an i NOS-driven-COX-2 inter-dependent pathway. This response could be reversed by dynamic compression. These data indicate interactions exist between the NOS and COX pathways, a finding which will provide new insights in the development of pharmacological or biophysical treatments for cartilage disorders such as OA.
机译:NO和PGE2是衍生自诱导I NOS和COX酶的炎症介质,并且是OA中的潜在重要的药理学靶标。机械加载和IL-1Beta都将影响NO和PGE2的释放。因此,目前的研究检查了在存在和不存在选择性I NOS和COX-2抑制剂的情况下在琼脂糖构建体中培养的人软骨细胞的动态压缩对NO和PGE2释放的影响。目前的数据表明,IL-1BETA诱导亚硝酸盐和PGE2释放并抑制[H] - β-β-噻吩并掺入。抑制剂实验表明,1400W和NS-398部分反转或废除IL-1BETA诱导的亚硝酸盐和PGE2释放。 IL-1Beta诱导细胞增殖和蛋白多糖合成的抑制与1400W相反,但不受NS-398的影响。对于动态载荷实验,1400W和NS-398要么减少或废除在IL-1Beta存在下的压缩诱导的“NO和PGE2释放”。 IL-1Beta诱导的细胞增殖抑制不受1400W或NS-398的影响,而1400W的菌株诱导的蛋白多糖合成的蛋白多糖合成的刺激得到1400W。使用人软骨细胞获得的数据证明IL-1BETA诱导NO和PGE2通过I NOS-DRIVE-COX-2相互依赖性途径释放。这种响应可以通过动态压缩来逆转。这些数据表明NOS和COX途径之间存在相互作用,该发现将为软骨障碍等药物或生物物理治疗的发展提供新的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号